|134.95|| +0.06 / +0.04%|
Bio-Rad Laboratories, Inc. is engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical and other life science research applications. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify its components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment is at the forefront of discovery, creating advanced tools to answer complex biological questions. Its products are used in established research techniques, biopharmaceutical production processes and food testing regimes. These techniques are typically used to separate, purify and identify biological materials such as proteins, nucleic acids and bacteria within a laboratory or production setting. This segment focuses on selected segments of the life sciences market in proteomics the study of proteins, genomics the study of genes, biopharmaceutical production, and cell biology and food safety. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. Its products currently address specific niches within the in vitro diagnostics test market, and the company focuses on the higher margin, higher growth segments of this market. IVD tests are conducted outside the human body and are used to identify and measure substances in a patient's tissue, blood or urine. Bio-Rad Laboratories was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
|Norman D. Schwartz||Chairman, President & Chief Executive Officer|
|John Goetz||Chief Operating Officer|
|Christine A. Tsingos||CFO, Executive VP & Head-Investor Relations|
|John Hertia||EVP & President-Clinical Diagnostics Group|
|Shannon Hall||Executive VP & President-Life Science Group|